-
Mashup Score: 4
Gilead’s CEO says he’s committed to making sure people around the world can get his firm’s new HIV prevention shot Yeztugo.
Source: www.statnews.comCategories: General Medicine NewsTweet
-
Mashup Score: 2Cogent Biosciences-Blueprint Medicines tiff turns spicy on eve of immune drug study readout - 2 hour(s) ago
A rivalry between two drugmakers, Cogent Biosciences and Blueprint Medicines, has turned ugly.
Source: www.statnews.comCategories: General Medicine NewsTweet
-
Mashup Score: 7Top gene therapy regulator forced out at FDA - 3 hour(s) ago
Nicole Verdun, director of the office that reviews cell and gene therapies at the Food and Drug Administration, and her deputy Rachael Anatol have been
Source: www.statnews.comCategories: General Medicine NewsTweet
-
Mashup Score: 1U.K. decision blocks a pair of Alzheimer’s drugs from access through its national health service - 3 hour(s) ago
A U.K. health agency said the Alzheimer’s drugs Kisunla and Leqembi are not cost-effective, meaning they won’t be offered through the NHS.
Source: www.statnews.comCategories: General Medicine NewsTweet
-
Mashup Score: 3
New brain-computer interface reduced time lag in translating thoughts into speech in a meaningful advance for the field.
Source: www.statnews.comCategories: General Medicine NewsTweet
-
Mashup Score: 1
Why did the Food and Drug Administration suddenly oust one of its top gene therapy regulators?
Source: www.statnews.comCategories: General Medicine NewsTweet
-
Mashup Score: 6
Two advocates demand systemic change in addiction treatment that prioritizes safety and accountability above all else.
Source: www.statnews.comCategories: General Medicine NewsTweet
-
Mashup Score: 9Cogent Biosciences-Blueprint Medicines tiff turns spicy on eve of immune drug study readout - 12 hour(s) ago
A rivalry between two drugmakers, Cogent Biosciences and Blueprint Medicines, has turned ugly.
Source: www.statnews.comCategories: General Medicine NewsTweet
-
Mashup Score: 4What's next for Sarepta Therapeutics with gene therapy under fire? - 13 hour(s) ago
The death of a boy with Duchenne muscular dystrophy, tied to a gene therapy, is above all a tragedy. But it is also undermining investor confidence in the company that makes it.
Source: www.statnews.comCategories: General Medicine NewsTweet
-
Mashup Score: 10
Emotionally intelligent AI can generate trust, motivate action, elevate the relationship between patients and their care teams, and drive meaningful change.
Source: www.statnews.comCategories: General Medicine NewsTweet
Gilead’s CEO on the approval of a powerful new drug to prevent HIV https://t.co/SturiBXHXL